Clinical Trial Update: Intranasal Dexmedetomidine for Sedated Hearing Testing [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intranasal dexmedetomidine for sedated hearing testing using Auditory Brainstem Response has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Auditory Brainstem Response

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Fondation Lenval | Conditions: Auditory Brainstem Response | Phase 3 | Status: COMPLETED